HealthCor Management’s Dynavax Technologies DVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-4,613,280
Closed -$42.2M 56
2018
Q4
$42.2M Buy
4,613,280
+1,491,811
+48% +$16.5M 1.32% 27
2018
Q3
$38.7M Buy
3,121,469
+590,362
+23% +$7.99M 1.28% 29
2018
Q2
$38.6M Buy
2,531,107
+1,212,495
+92% +$21M 1.23% 29
2018
Q1
$26.2M Buy
+1,318,612
New +$22.8M 0.89% 36
2014
Q2
Sell
-479,498
Closed -$8.67M 57
2014
Q1
$8.67M Sell
479,498
-1,520,502
-76% -$28.2M 0.52% 38
2013
Q4
$39.2M Buy
2,000,000
+240,000
+14% +$3.51M 2.38% 14
2013
Q3
$20.9M Hold
1,760,000
1.12% 32
2013
Q2
$19.4M Buy
+1,760,000
New +$37.1M 1.17% 28

Other funds holding DVAX

HealthCor Management's DVAX Position: Q1 2019 in Review

HealthCor Management sold out of Dynavax Technologies (DVAX) in Q1 2019, closing a stake of 4,613,280 shares — an estimated $42.2M sold.

HealthCor Management first reported a position in DVAX in Q2 2013 and held it in 8 quarters. The position peaked at $42.2M in Q4 2018. 137 funds tracked by Wall St. Rank hold DVAX as of Q1 2019.

  • HealthCor Management reported no remaining Dynavax Technologies position as of Q1 2019 after selling out during the quarter.
  • HealthCor Management sold 4,613,280 Dynavax Technologies shares in Q1 2019, an estimated $42.2M.
  • HealthCor Management first reported a position in Dynavax Technologies in Q2 2013 and held it in 8 quarters.
  • HealthCor Management's Dynavax Technologies position peaked at $42.2M in Q4 2018.
  • 137 funds tracked by Wall St. Rank held Dynavax Technologies as of Q1 2019.

Based on HealthCor Management's 13F filing for Q1 2019, filed 15 May 2019.